Le Lézard
Classified in: Covid-19 virus
Subjects: Product/Service, Statement

Alveo Technologies Announces ISO 13485:2016 Certification

Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.welltm technology platform, today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease.

The globally recognized ISO 13485 standard, published by the International Standards Organization, sets out requirements for establishing and maintaining quality management systems for the medical device industry.

Compliance with the ISO 13485 standard is required for companies to market medical devices in many markets, including the European Union, Canada, Japan, and Australia. In addition, the U.S. Food and Drug Administration has announced plans to harmonize its existing medical device QMS requirements with ISO 13485, proposing new regulations that incorporate ISO 13485 as the foundational requirements.

"We are thrilled to achieve ISO 13485 certification," says Alveo CEO Shaun Holt. "This official recognition from our notified body confirms that Alveo Technologies has developed a state-of-the-art quality management system that consistently delivers highly sensitive and specific molecular sensing and diagnostic results. We are committed to maintaining this standard and driving quality for our customers and partners."

"I would like to emphasize that this is more than a piece of paper ? it is proof positive to the world that our intense focus on quality has been independently verified," Holt says. "Moreover, this assures current and future partners in agriculture, veterinary sciences, and aquaculture that we bring a high level of quality to their projects, their markets, and customers. "

Alveo has developed a rapid, handheld, eco-friendly, multiplexed platform that pairs advanced molecular assays with cloud-enabled data analytics for real-time disease, pathogen and contaminant detection, analysis, and diagnosis. This mobile molecular lab is capable of delivering rapid testing at the point of need, for example, in doctor's offices for various infectious diseases, in the field for crop testing, or on farms for livestock testing. Alveo is leading the transformation of the point-of-need molecular sensing and health tech markets with an open-platform approach to co-developing rapid molecular testing capabilities with collaborative partners across multiple markets. Initially focused on COVID-19 testing, the company has commercialized its be.welltm COVID-19 Test in the European Union, Middle East, and the Caribbean on the back of this certification.

Alveo's conformity assessment was performed by GMED-LNE, a highly regarded French notified body globally renowned for its expertise in assessing medical device quality management systems for conformance to the standard. GMED (CE 0459) is designated as a Notified Body under Regulation (EU) 2017/746 and is one of only a few authorized to provide certification services to manufacturers according to Regulation (EU) 2017/746 (IVDR).

"This certification from GMED, one of the world's most respected notified bodies, confirms that we have a top-notch quality management system for the design and development of compliant IVD products," says Kevin Gunning, Vice President of Quality at Alveo. "In executing against our development pipeline, our QMS processes give us a high degree of confidence that the products we manufacture will continually meet customer expectations and regulatory requirements."

About Alveo
At Alveo we understand the importance of access to cutting-edge molecular testing and cloud-based data analytics for rapid diagnosis and management of infectious diseases and other pathogens. With an initial focus on acute respiratory infections including COVID-19, Flu A/B and RSV, Alveo's agile and dynamic molecular sensing and diagnostic platform, be.welltm, can be adapted to detect a wide range of diseases, bacteria, and other pathogens that threaten public health, across all modalities. We believe increased access to real-time test results will transform the way individuals, healthcare providers and public health professionals identify and manage pathogens in humans, animals, plants, water, and beyond. With be.welltm, we will Know Sooner, Act Fastertm.

To learn more, visit https://alveotechnologies.com

These press releases may also interest you

at 17:30
Elevated Minds, a mental health organization founded by Dr. Leeshe N. Grimes, a retired United States Army veteran, psychotherapist, and motivational speaker, has announced their plans to expand their services to different states and countries, with...

at 11:00
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beyond Meat, Inc. ("Beyond Meat" or the "Company") and reminds investors of the July 10, 2023 deadline to seek the role of lead plaintiff in a...

at 11:00
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cutera, Inc. ("Cutera" or the "Company") and reminds investors of the July 24, 2023 deadline to seek the role of lead plaintiff in a federal...

at 00:15
Registration for the 10th Annual Patient Safety, Science & Technology Summit is now closed. This in-person Summit marks the nonprofit's 10th anniversary and will be held in Newport Beach, California, from June 1 to 2. "We are very encouraged at the...

26 mai 2023
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against  Beyond...

26 mai 2023
The ambulatory healthcare service market size is set to grow by USD 1207.02 billion between 2022 and 2027 and register a CAGR of  6.38%, according to Technavio's latest market research report. With a focus on identifying dominant industry...

News published on and distributed by: